Mosaicism in Fanconi anemia: concise review and evaluation of published cases with focus on clinical course of blood count normalization

Ann Hematol. 2020 May;99(5):913-924. doi: 10.1007/s00277-020-03954-2. Epub 2020 Feb 17.


Fanconi anemia (FA) is a DNA repair disorder resulting from mutations in genes encoding for FA DNA repair complex components and is characterized by variable congenital abnormalities, bone marrow failure (BMF), and high incidences of malignancies. FA mosaicism arises from reversion or other compensatory mutations in hematopoietic cells and may be associated with BMF reversal and decreased blood cell sensitivity to DNA-damaging agents (clastogens); this sensitivity is a phenotypic and diagnostic hallmark of FA. Uncertainty regarding the clinical significance of FA mosaicism persists; in some cases, patients have survived multiple decades without BMF or hematologic malignancy, and in others hematologic failure occurred despite the presence of clastogen-resistant cell populations. Assessment of mosaicism is further complicated because clinical evaluation is frequently based on clastogen resistance in lymphocytes, which may arise from reversion events both in lymphoid-specific lineages and in more pluripotent hematopoietic stem/progenitor cells (HSPCs). In this review, we describe diagnostic methods and outcomes in published mosaicism series, including the substantial intervals (1-6 years) over which blood counts normalized, and the relatively favorable clinical course in cases where clastogen resistance was demonstrated in bone marrow progenitors. We also analyzed published FA mosaic cases with emphasis on long-term clinical outcomes when blood count normalization was identified. Blood count normalization in FA mosaicism likely arises from reversion events in long-term primitive HSPCs and is associated with low incidences of BMF or hematologic malignancy. These observations have ramifications for current investigational therapeutic programs in FA intended to enable gene correction in long-term repopulating HSPCs.

Keywords: Autologous stem cell transplantation; Bone marrow failure; Fanconi anemia; Gene therapy; Mosaicism.

Publication types

  • Evaluation Study
  • Systematic Review

MeSH terms

  • Bone Marrow Cells / metabolism*
  • Bone Marrow Cells / pathology
  • Fanconi Anemia* / blood
  • Fanconi Anemia* / diagnosis
  • Fanconi Anemia* / genetics
  • Fanconi Anemia* / therapy
  • Hematologic Neoplasms* / blood
  • Hematologic Neoplasms* / diagnosis
  • Hematologic Neoplasms* / genetics
  • Hematologic Neoplasms* / therapy
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Mosaicism*